WFL 0.00% 0.3¢ wellfully limited

european patent, page-32

  1. 2,323 Posts.
    lightbulb Created with Sketch. 337
    Hi stilo, this is pretty cool technology - especially for diabetics who will ultimately have real-time and continuous access to their own blood sugar levels.

    The difference between EchoT and OBJ is that the former requires 'painless' removal of the stratus corneum to allow analyte extraction and from that blood sugar levels are calculated and sent to a wireless sensor. OBJ tech is non-invasive but only has one-way movemnet transdermally.

    I very much agree with your sentiment about an near term need to commercialise our technology

    bluebush
 
watchlist Created with Sketch. Add WFL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.